Patients With Atherosclerotic Vascular Disease: How Low Should Plasma Homocyst(e)ine Levels Go?

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.2, 2001-01, pp. : 85-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homocyst(e)ine and Coronary Heart Disease: Pharmacoeconomic Support for Interventions to Lower Hyperhomocyst(e)inaemia

By Nallamothu B.K.

PharmacoEconomics, Vol. 20, Iss. 7, 2002-01 ,pp. : 429-442

Adis International

Access to resources Recommend Favorite

Asymmetric Dimethyl-L-Arginine (ADMA): A Possible Link Between Homocyst(e)ine and Endothelial Dysfunction

Current Drug Metabolism, Vol. 6, Iss. 1, 2005-02 ,pp. : 3-14

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-Lowering Treatment in Coronary Artery Disease: How Low Should Cholesterol Go?

By Jones P.H.

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1127-1135

Adis International

Access to resources Recommend Favorite

Homocysteine and Non-Cardiac Vascular Disease

Current Pharmaceutical Design, Vol. 23, Iss. 22, 2017-09 ,pp. : 3224-3232

Bentham Science Publishers

Access to resources Recommend Favorite

Antihypertensive therapy in stroke: how low should you go?

Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite